Anna Nowak

Professor, MB BS PhD W.Aust., FRACP

  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 7262 Citations
  • 46 h-Index
20012023
If you made any changes in Pure these will be visible here soon.

Research Output 2002 2019

Filter
Abstract/Meeting Abstract
2019

Molecular Determinants of Autoimmunity and Immune Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors (Auto-Check Study)

Yip, S., Stockler, M., Yip, D., Nowak, A., Mitchell, P., Antill, Y., Andrews, D., Lee, C., Gedye, C., Khasraw, M., Robledo, K., Parry, M., Vinuesa, C., Ali, S., Lesterhuis, J. & Cook, M., Jul 2019, In : Asia-Pacific Journal of Clinical Oncology. 15, p. 59-59 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Neurocognitive outcomes in a phase-3 randomised trial comparing adjuvant whole brain radiotherapy with observation after local treatment of brain metastases in patients with melanoma

Dhillon, H., Fogarty, G. B., Dolven-Jacobsen, K., Morton, R. L., Hruby, G., Nowak, A. K., Vardy, J. L., Drummond, K. J., Mandel, C., Scolyer, R. A., Shivalingam, B., Middleton, M. R., Burmeister, B., Roos, D. E., Lo, S. N., Reisse, C. H., Paton, E. J., Williams, N. C., Thompson, J. F. & Hong, A., Nov 2019, In : Asia-Pacific Journal of Clinical Oncology. 15, p. 99-100 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Phase 3 International Trial of Adjuvant Whole Brain Radiotherapy (WBRT) or Observation (OBS) Following Local Treatment of 1-3 Melanoma Brain Metastases (MBMs)

Fogarty, G. B., Dolven-Jacobsen, K., Morton, R. L., Hruby, G., Nowak, A. K., Vardy, J. L., Drummond, K. J., Dhillon, H. M., Mandel, C., Scolyer, R. A., Shivalingam, B., Middleton, M. R., Burmeister, B., Roos, D. E., Lo, S. N., Reisse, C. H., Paton, E. J., Williams, N. C., Thompson, J. F. & Hong, A., 1 Sep 2019, In : INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 105, 1, p. S139-S140 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study

Lam, W., Nowak, A., Chen, F., Muruganandan, S., Arunachalam, S., Chin, M., Millward, M., Read, C., Murray, K., Creaney, J. & Lee, Y. C. G., Oct 2019, In : Journal of Thoracic Oncology. 14, 10, p. S342-S342 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

SECOND INTERIM AND FIRST MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1P/19Q CODELETION

van den Bent, M. J., Erridge, S., Vogelbaum, M. A., Nowak, A. K., Sanson, M., Brandes, A. A., Wick, W., Clement, P. M., Baurain, J. F., Mason, W., Wheeler, H., Weller, M., Aldape, K., Wesseling, P., Kros, J. M., Tesileanu, C. M. S., Golfinopoulos, V., Gorlia, T., Baumert, B. G. & French, P. J., Aug 2019, In : Neuro-Oncology. 21, p. 3-3 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Test-Retest Repeatability of 18F-FET PET in Small Volumes

Ferjancic, P., Ebert, M. A., Nowak, A. K., Francis, R. J. & Jeraj, R., Jun 2019, In : Medical Physics. 46, 6, p. E398-E398 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2018

Clinical implementation of personalised medicine for six high priority WA cancers

Humphries, T., Robinson, C., Giardina, T., Nowak, A., Robinson, S., Iacopetta, B., Stewart, C., Meniawy, T., Kumarasinghe, P., Wood, B., Thomas, C., De Boer, B., Leung, Y., Robbins, P., Van Hazel, G., Ferguson, T., Raftopoulos, S., Millward, M. & Amanuel, B., Nov 2018, In : Asia-Pacific Journal of Clinical Oncology. 14, p. 157-158 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Impact of Tumor Volume on Outcome: What Are the Limitations?

Nowak, A., Oct 2018, In : Journal of Thoracic Oncology. 13, 10, p. S293-S294 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2017

A CASE SERIES OF LEVETIRACETAM-RELATED PSYCHIATRIC SYMPTOMS

Hercus, C., Verheggen, M., Nowak, A. & Miller, L., May 2017, In : Australian & New Zealand Journal of Psychiatry. 51, p. 152-153 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

A MULTICENTER, 3-ARM, OPEN-LABEL, PHASE IIA CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF TANIBIRUMAB (VEGFR2 MAB), IN PATIENTS WITH RECURRENT GBM ASSESSED WITH K-TRANS AND INITIAL AREA UNDER THE GADOLINIUM CONCENTRATION-TIME CURVE (IAUGC)

Cher, L., Nowak, A., Iatropoulos, G., Lee, W. S., Lee, S. Y., Shim, S. R. & Yoo, J. S., Nov 2017, In : Neuro-Oncology. 19, p. 17-17 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

A Phase II Trial of the Oral FGF Receptor Inhibitor AZD4547 as 2nd or 3rd Line Therapy in Malignant Pleural Mesothelioma - Trial in Progress

Lam, W-S., Lee, Y. C. G., Creaney, J., Muruganandan, S., Millward, M., Read, C. & Nowak, A., Jan 2017, In : Journal of Thoracic Oncology. 12, 1, p. S1087-S1087 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2 Citations (Scopus)

Exercise Medicine for Brain Cancer: Safety and Feasibility of Supervised Exercise during Adjuvant Treatment of High-Grade Glioma

Cormie, P., Zopf, E., Halkett, G., Tsoi, D., Hasani, A., Galvao, D., Newton, R. & Nowak, A., Nov 2017, In : Asia-Pacific Journal of Clinical Oncology. 13, p. 212-212 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Feasibility and Preliminary Efficacy of a 6-Week Exercise Intervention in Patients with Malignant Pleural Disease

McIntyre, C. J., Jeffery, E., Lee, Y. C. G., Nowak, A. K., Nguyen, B. & Newton, R. U., Nov 2017, In : Asia-Pacific Journal of Clinical Oncology. 13, p. 218-219 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Nintedanib plus pemetrexed/cisplatin in patients with MPM: Phase II findings from the placebo-controlled LUME-Meso trial

Grosso, F., Steele, N., Novello, S., Nowak, A., Popat, S., Greillier, L., von Wangenheim, U., Morsli, N., Barrueco, J. & Scagliotti, G., Oct 2017, In : Annals of Oncology. 28, 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Overall survival (OS) and forced vital capacity (FVC) results from the LUME-Meso study of nintedanib (N) plus pemetrexed/cisplatin (PEM/CIS) vs placebo (P) plus PEM/CIS in chemo-naive patients (pts) with malignant pleural mesothelioma (MPM)

Novello, S., Nowak, A. K., Grosso, F., Steele, N., Popat, S., Greillier, L., John, T., Leighl, N. B., Reck, M., Pavlakis, N., Sorensen, J. B., Planchard, D., Ceresoli, G. L., Hughes, B., Mazieres, J., Socinski, M. A., von Wangenheim, U., Barrueco, J., Morsli, N. & Scagliotti, G., Sep 2017, In : Annals of Oncology. 28, 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Participating in Exercise during Chemoradiotherapy Helps Patients Diagnosed with High Grade Glioma to Feel Stronger and Actively Involved in Their Fight Against Cancer: A Qualitative Study

Halkett, G., Cormie, P., Zopf, E., Tsoi, D., Hasani, A., Galvao, D., Newton, R. & Nowak, A., Nov 2017, In : Asia-Pacific Journal of Clinical Oncology. 13, p. 215-215 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

PREDICTION MODELING USING ROUTINE CLINICAL PARAMETERS TO STRATIFY SURVIVAL IN MESOTHELIOMA PATIENTS UNDERGOING SURGERY

Harris, E., Kao, S., Nakano, T., Kondo, N., Nowak, A. & Brims, F., Nov 2017, In : Respirology. 22, p. 67-68 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

20 Citations (Scopus)

PSYCHO-ONCOLOGY AND PALLIATIVE CARE

Miller, L., Hercus, C., Verheggen, M., Nowak, A., Kelly, B., Dwyer, J., Proskurin, H. & Wilson, F., May 2017, In : Australian & New Zealand Journal of Psychiatry. 51, p. 23-23 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

7 Citations (Scopus)

SEROUS RETINAL DETACHMENT DUE TO FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR IN MALIGNANT PLEURAL MESOTHELIOMA

Arunachalam, S., Lam, W-S., Nowak, A., Creaney, J., Millward, M., Muruganandan, S., Read, C., Lee, G. & Chen, F., Oct 2017, In : Clinical & Experimental Ophthalmology. 45, p. 135-135 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

SLEEP DISTURBANCE AMONG ADULT PATIENTS WITH PRIMARY AND SECONDARY BRAIN TUMORS AND THEIR CAREGIVERS: A CROSS-SECTIONAL STUDY

Jeon, M., Dhillon, H., Koh, E-S., Nowak, A., Lam, L., Miller, L., Marshall, N. & Agar, M., Nov 2017, In : Neuro-Oncology. 19, p. 206-207 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA

Brandes, A., Gil Gil, M., Saran, F., Carpentier, A. F., Nowak, A., Mason, W., Dubois, F., Finocchiaro, G., Fountzilas, G., Zagonel, V., Cernea, D. M., Chinot, O., Makrutzki, M., Mpofu, C., Urban, H-J. & Pichler, J., Nov 2017, In : Neuro-Oncology. 19, p. 17-18 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2015

The Improving Rural Cancer Outcomes (IRCO) Trial: a factorial cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural cancer patients in Western Australia

Emery, J., Gray, V., Walter, F., Cheetham, S., Croager, E., Slevin, T., Saunders, C., Threlfall, T., Auret, K., Nowak, A., Geelhoed, E., Bulsara, M. & Holman, C., 2015, In : European Journal of Cancer Care. 24, Supp. S2, p. 23-23 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2014